Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Tangible Net Worth Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Tangible Net Worth Ratio of 93.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥110.68 Million) from net assets (CN¥1.60 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is Hunan Dajiaweikang Pharmaceutical Indust's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Tangible Net Worth Ratio (2019–2025)
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 93.1%, reflecting net assets of CN¥1.60 Billion with intangible assets of CN¥110.68 Million CNY. Also explore 301126 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 301126 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.9% | CN¥1.59 Billion | CN¥112.49 Million | CN¥6.34 Billion | ▲ +0.3 pp |
| 2024 | 92.7% | CN¥1.85 Billion | CN¥135.72 Million | CN¥6.18 Billion | ▲ +0.4 pp |
| 2023 | 92.2% | CN¥1.78 Billion | CN¥138.17 Million | CN¥5.28 Billion | ▼ -2.1 pp |
| 2022 | 94.3% | CN¥1.82 Billion | CN¥103.55 Million | CN¥3.93 Billion | ▼ -4.2 pp |
| 2021 | 98.5% | CN¥1.68 Billion | CN¥25.83 Million | CN¥2.99 Billion | ▲ +1.0 pp |
| 2020 | 97.5% | CN¥1.04 Billion | CN¥26.25 Million | CN¥2.20 Billion | ▲ +0.2 pp |
| 2019 | 97.2% | CN¥977.24 Million | CN¥27.02 Million | CN¥2.02 Billion | — |